Recombinant Variola virus Virion membrane protein A14 (A14L, A15L)

Shipped with Ice Packs
In Stock

Description

Functional Role in Viral Replication

Research on Vaccinia virus A14L homologs provides insights into its biological role:

  • Membrane biogenesis: Essential for organizing ERGIC-derived membranes into viral crescents .

  • Morphogenesis: Conditional knockout mutants (e.g., VVindA14L) show disrupted virion assembly, with disorganized membranous elements and impaired core protein processing .

  • Virulence: Deletion of adjacent genes (e.g., A14.5L) reduces pathogenicity in animal models, suggesting cooperative roles in virulence .

Key experimental findings:

ObservationImplicationSource
A14L repression reduces viral yield by >99%Critical for progeny production
Membranes fail to attach to viral factoriesStabilizes membrane-virosome interactions
Core protein cleavage inhibitionLinks membrane assembly to maturation

Production and Applications

Expression systems:

  • Hosts: E. coli, yeast, baculovirus, mammalian cells, or cell-free systems .

  • Tags: Variably includes GST, His, or other tags depending on the production method .

Research applications:

ApplicationUse CaseSource
Antibody productionImmunogen for ELISA/Western blot
Structural studiesMembrane protein interaction assays
Vaccine developmentAntigen for poxvirus research

Pathogenicity and Medical Relevance

  • Animal models: A14.5L deletion in Vaccinia attenuates murine virulence, highlighting the importance of A14L-associated genomic regions in vivo .

  • Therapeutic targeting: Potential candidate for antiviral drug design due to its essential role in virion assembly .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we are happy to accommodate any specific format requirements you may have. Please specify your desired format in the order notes, and we will prepare accordingly.
Lead Time
Delivery times may vary depending on your location and purchase method. Please contact your local distributor for specific delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless otherwise specified. If you require dry ice shipping, please inform us in advance. Additional fees may apply.
Notes
Repeated freezing and thawing is not recommended. For optimal stability, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial prior to opening to ensure the contents are collected at the bottom. Reconstitute the protein in deionized sterile water to a final concentration of 0.1-1.0 mg/mL. We suggest adding 5-50% glycerol (final concentration) and aliqouting for long-term storage at -20°C/-80°C. Our standard final concentration of glycerol is 50%, which can serve as a reference.
Shelf Life
Shelf life is influenced by various factors, including storage conditions, buffer components, temperature, and the inherent stability of the protein itself.
Generally, liquid form has a shelf life of 6 months at -20°C/-80°C. Lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type will be determined during production. If you have a specific tag type in mind, please inform us, and we will prioritize its development for your order.
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-90
Protein Length
full length protein
Species
Variola virus (isolate Human/India/Ind3/1967) (VARV) (Smallpox virus)
Target Names
A14L
Target Protein Sequence
MDMMLMIGNYFSGVLIAGIILLILSCIFAFIDFSKSTSPTRTWKVLSIMSFILGIIITVG MLIYSMWGKHCAPHRVSGVIHTNHSDISVN
Uniprot No.

Q&A

What is the Function of A14 Protein in Poxvirus Membrane Biogenesis?

A14 is a critical transmembrane protein required for vaccinia virus membrane biogenesis, likely serving similar functions in variola virus. Research has demonstrated that in the absence of A14, viral morphogenesis is significantly disrupted, resulting in the accumulation of electron-dense virosomes and distinct clusters of small vesicles . A14 participates in the earliest stages of membrane formation alongside other viral proteins, including the F10 protein kinase and the H7, A11, L2, and A6 nonstructural proteins .

Functionally, A14 adopts a hairpin conformation spanning the membrane twice and contains biologically significant motifs within its N-terminal and central loop regions that affect crescent maturation and the immature virion (IV) to mature virion (MV) transition . These structural characteristics enable A14 to play an essential role in the proper formation and assembly of the viral membrane.

How Does A14 Interact with Other Viral Proteins During Assembly?

A14 forms a critical interaction partnership with A17, another transmembrane protein required for vaccinia virus membrane biogenesis. Both proteins adopt hairpin conformations but with opposite polarities in their membrane orientation . Experimental evidence shows that:

  • A14 and A17 can associate with membranes co-translationally but not post-translationally

  • Their interaction appears essential for proper membrane formation

  • Mutations in specific motifs of A14 can affect the IV to MV transition without disrupting the A14-A17 interaction

This suggests that while the A14-A17 interaction is important, A14 likely serves additional functions independent of this interaction that are critical for virion maturation. The coordination between these proteins establishes the foundation for the complex membrane architecture of poxviruses.

What Methodologies Are Effective for Expression and Purification of Recombinant A14?

The membrane-embedded nature of A14 presents unique challenges for recombinant expression and purification. Based on its characteristics, researchers should consider the following approaches:

Table 1: Expression Systems for Recombinant A14 Protein

Expression SystemAdvantagesLimitationsSpecial Considerations
Bacterial (E. coli)Cost-effective, high yieldChallenging for membrane proteinsRequires fusion partners or refolding strategies
Insect cells (Baculovirus)Better folding of complex proteinsModerate cost, longer production timePreferred for structural studies
Mammalian cellsNative-like environmentHigher cost, lower yieldOptimal for functional studies
Cell-free with microsomesControls translation environmentTechnical complexitySuitable given A14's co-translational membrane association

For purification, researchers should implement detergent solubilization followed by affinity chromatography (using epitope tags) and size exclusion chromatography. For structural studies, reconstitution into nanodiscs or liposomes may preserve the native conformation of A14.

How Do Mutations in A14 Affect Virion Morphogenesis?

Structure-function analysis using inducible recombinants has revealed critical insights into A14's role in virion assembly . Specific findings include:

  • Mutations in the N-terminal or central loop regions of A14 significantly impact crescent maturation and the IV to MV transition

  • When A14 is absent entirely, electron-dense virosomes and clusters of small vesicles accumulate, preventing proper virion formation

  • When mutant A14 proteins are induced at 12 hours post-infection, crescents appear at the periphery of electron-dense virosomes

These observations suggest that different domains of A14 serve specific functions during the complex process of membrane biogenesis and virion maturation. The timing of A14 expression appears critical, as late induction can partially restore membrane formation.

What Are the Structural Characteristics of A14 Protein?

While detailed structural data specific to variola virus A14 is limited in the available literature, information from vaccinia virus studies indicates:

  • A14 likely adopts a hairpin conformation in the membrane

  • The protein spans the membrane twice, with specific orientation

  • Biologically important motifs exist within the N-terminal and central loop regions

  • The structural arrangement facilitates interaction with A17 and potentially other viral proteins

Modern structural prediction tools similar to those used for other poxvirus proteins could be applied to generate detailed models of A14 structure . Such models would enhance understanding of A14's functional domains and interaction interfaces.

What Experimental Systems Are Available to Study A14 Function?

Several experimental approaches have proven effective for investigating A14 function:

Table 2: Experimental Systems for A14 Functional Studies

Experimental SystemApplicationKey AdvantagesNotable Findings
Inducible recombinantsTemporal control of expressionAllows timing-specific analysisRevealed role of A14 in crescent formation
Mutational analysisStructure-function mappingIdentifies critical domainsDemonstrated importance of N-terminal region
Electron microscopyVisualize morphological effectsDirect observation of assembly defectsShowed vesicle accumulation in A14 absence
Protein-protein interaction assaysMap interaction networksIdentifies functional partnersEstablished A14-A17 relationship
Knockout virusesAssess essential functionsClear loss-of-function phenotypeConfirmed critical role in membrane biogenesis

Given restrictions on live variola virus research, most studies on variola A14 would need to be conducted in WHO-certified facilities or using appropriate surrogate systems .

How Does A14 Research Contribute to Antiviral Development?

A14's essential role in poxvirus membrane biogenesis makes it a potential target for antiviral development. The World Health Organization has emphasized the need for continued research with variola virus to develop "newer and safer vaccines, fully licensed antiviral drugs, and better diagnostics" . Research on A14 contributes to this agenda in several ways:

  • Identifying essential protein-protein interactions that could be disrupted by small molecules

  • Understanding membrane biogenesis as a distinct target pathway from currently approved antivirals

  • Providing structural information to guide rational drug design

  • Offering potential broad-spectrum targets against multiple poxviruses

The central role of A14 in virion formation suggests that effective inhibitors could significantly impair viral replication. This research aligns with the WHO's goals for developing interventions against poxviruses .

What Are the Key Considerations for Designing A14 Functional Experiments?

When planning experiments to investigate A14 function, researchers should consider:

  • Experimental system selection: Given variola virus research restrictions, appropriate model systems must be carefully chosen

  • Temporal regulation: Inducible expression systems allow precise control of when A14 is expressed during infection

  • Detection methods: Specialized techniques for membrane protein visualization and functional assessment

  • Controls: Appropriate wild-type, knockout, and complementation controls to validate findings

  • Biosafety requirements: Adherence to WHO guidelines for research involving poxvirus components

For membrane biogenesis studies specifically, electron microscopy remains invaluable for assessing morphological effects of A14 manipulation . Complementation assays testing whether recombinant A14 can rescue defects in A14-deficient viruses provide robust functional validation.

How Can Structural Analysis Techniques Be Applied to Study A14?

Modern structural biology approaches can provide valuable insights into A14 function:

  • Computational prediction: AlphaFold or similar tools can generate structural models to guide experimental design

  • X-ray crystallography: Potentially applicable to soluble domains or stabilized full-length protein, as demonstrated for other poxvirus proteins

  • Cryo-electron microscopy: Ideal for visualizing A14 in its membrane context

  • Structural homology screening: Can identify unexpected relationships with host proteins, as demonstrated for other poxvirus proteins like A47L

The structural homology approach has proven particularly valuable for poxvirus proteins, revealing that vaccinia A47L is a homolog of gasdermins that inhibits pyroptosis . Similar unexpected functional relationships might be discovered for A14 through structural analysis.

How Does Variola A14 Compare to Orthologues in Other Poxviruses?

While the search results don't provide direct comparisons between variola and other poxvirus A14 proteins, general principles about poxvirus evolution suggest:

  • Core structural features of A14 are likely conserved across orthopoxviruses

  • Subtle sequence variations might contribute to host range differences

  • Functional interactions with other viral proteins are probably maintained

Notably, variola virus is unique among orthopoxviruses as a sole human pathogen , suggesting potential adaptations in its proteins, possibly including A14, that contribute to this strict host tropism. Comparative genomic and structural analyses could reveal specific features of variola A14 that differ from other poxvirus orthologues.

What Role Might A14 Play in Host-Pathogen Interactions?

While direct evidence for A14's role in host-pathogen interactions is limited in the provided materials, several hypotheses can be proposed based on its functions:

  • A14 may interact with host membrane-shaping proteins during virion assembly

  • As a membrane protein, A14 could potentially be recognized by innate immune sensors

  • A14's role in membrane biogenesis might indirectly affect the display of other viral proteins to the host immune system

  • Specific features of variola A14 might contribute to the virus's strict human tropism

Similar to the approach used for vaccinia A47L, which was found to inhibit pyroptosis , structural and functional studies of A14 could reveal unexpected interactions with host cellular pathways.

What Challenges Exist in Studying A14 in the Context of Variola Research?

Several significant challenges impact variola A14 research:

  • Regulatory restrictions: Research with live variola virus is limited to WHO-certified facilities

  • Biological containment: The highest biosafety levels are required for work with variola components

  • Animal model limitations: "Current animal models using variola virus do not faithfully recapitulate the human clinical disease process or immune responses"

  • Recombinant approach restrictions: "Recombinant genetic modification approaches are not condoned in use of variola"

Despite these challenges, the WHO has acknowledged that "research remains vital" for developing "newer and safer vaccines, fully licensed antiviral drugs, and better diagnostics" . A14 research contributes to understanding fundamental aspects of poxvirus biology that could inform these public health goals.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.